Status:
COMPLETED
Low Dose Magnesium Sulphate Versus Standard Pritchard Regimen In Management Of Severe Preeclampsia/Eclampsia
Lead Sponsor:
Adebayo Joshua Adeniyi
Conditions:
Preeclampsia/Eclampsia
Eligibility:
FEMALE
18-49 years
Phase:
NA
Brief Summary
Background - Preeclampsia/eclampsia, a pregnancy specific multi-systemic disease, is associated with considerable maternal and perinatal morbidity and mortality. Prevention and/or treatment of convuls...
Detailed Description
Introduction Preeclampsia complicates 5-7% of all pregnancies globally. However, hospital-based studies in Nigeria have reported rates ranging between 1.2% and 6.3%, while a study in Abakaliki recorde...
Eligibility Criteria
Inclusion
- Pregnant women with diagnosis of severe preeclampsia/eclampsia
Exclusion
- Administration of MgSO4 before admission.
- Administration of diazepam or phenytoin before admission
- Maternal complications such as disseminated intravascular coagulation, cerebrovascular accident, renal disease, HELLP syndrome and aspiration pneumonitis.
- Multiple gestation
- Gestational ages below 28 weeks
- Postpartum eclampsia
Key Trial Info
Start Date :
May 8 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 22 2018
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT04501289
Start Date
May 8 2017
End Date
January 22 2018
Last Update
August 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alex Ekwueme Federal University Teaching Hospital
Abakaliki, Abakaliki LG, Nigeria